CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
DOK1 | Docking protein 1, 62kDa (downstream of tyrosine kinase 1) | Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
EGR1 | Early growth response 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
EIF4EBP1 | Eukaryotic translation initiation factor 4E binding protein 1 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
FER | Fer (fps/fes related) tyrosine kinase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
FOXO1 | Forkhead box O1 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
GAL | Galanin/GMAP prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GRB2 | Growth factor receptor-bound protein 2 | Cancer-related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
HNF1A | HNF1 homeobox A | Cancer-related genes Predicted intracellular proteins
| | | | | Group enriched |
INPPL1 | Inositol polyphosphate phosphatase-like 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PAX6 | Paired box 6 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PCK1 | Phosphoenolpyruvate carboxykinase 1 (soluble) | Citric acid cycle related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PID1 | Phosphotyrosine interaction domain containing 1 | Predicted intracellular proteins
| | | | | Expressed in all |
PRKAA1 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PRKCA | Protein kinase C, alpha | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PRKCD | Protein kinase C, delta | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PSMD9 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PTPN2 | Protein tyrosine phosphatase, non-receptor type 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
RBP4 | Retinol binding protein 4, plasma | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
RELA | V-rel avian reticuloendotheliosis viral oncogene homolog A | Cancer-related genes Disease related genes Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
RPTOR | Regulatory associated protein of MTOR, complex 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
SESN3 | Sestrin 3 | Predicted intracellular proteins
| | | | | Expressed in all |
SNX15 | Sorting nexin 15 | Predicted intracellular proteins
| | | | | Expressed in all |
SYT8 | Synaptotagmin VIII | Predicted membrane proteins
| | | | | Tissue enhanced |
TRIB3 | Tribbles pseudokinase 3 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
UQCC2 | Ubiquinol-cytochrome c reductase complex assembly factor 2 | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
VGF | VGF nerve growth factor inducible | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ARRB1 | Arrestin, beta 1 | Predicted intracellular proteins
| | | | | Expressed in all |
CPE | Carboxypeptidase E | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DENND4C | DENN/MADD domain containing 4C | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
GNAS | GNAS complex locus | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
HNF1B | HNF1 homeobox B | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
PTRF | Polymerase I and transcript release factor | Disease related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
RAB13 | RAB13, member RAS oncogene family | Predicted intracellular proteins
| | | | | Expressed in all |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
YWHAG | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AKAP5 | A kinase (PRKA) anchor protein 5 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
AP3S1 | Adaptor-related protein complex 3, sigma 1 subunit | Predicted intracellular proteins
| | | | | Expressed in all |
APRT | Adenine phosphoribosyltransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ARNTL | Aryl hydrocarbon receptor nuclear translocator-like | Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |